Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1998-07-01 (27 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VALBONNE (06560), Alpes-Maritimes
PHARMACIE DU CHENE VERT : revenue, balance sheet and financial ratios
PHARMACIE DU CHENE VERT is a French company
founded 27 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VALBONNE (06560),
this company of category PME
shows in 2022 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CHENE VERT (SIREN 422099572)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
2 001 624 €
N/C
N/C
N/C
1 667 565 €
1 535 776 €
Net income
66 444 €
104 168 €
153 267 €
173 334 €
139 635 €
119 686 €
133 753 €
60 158 €
EBITDA
N/C
N/C
198 611 €
N/C
N/C
N/C
190 017 €
75 691 €
Net margin
N/C
N/C
7.7%
N/C
N/C
N/C
8.0%
3.9%
Revenue and income statement
In 2024, PHARMACIE DU CHENE VERT generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 60 k€ -> 66 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
66 444 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 19%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
18.795%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
73.485%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU CHENE VERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
7.865
6.675
1.245
1.474
3.516
1.248
19.449
18.795
Financial autonomy
81.448
83.268
88.384
87.335
85.046
84.396
74.434
73.485
Repayment capacity
1.358
0.519
None
None
None
0.094
None
None
Cash flow / Revenue
4.107%
8.502%
None%
None%
None%
7.796%
None%
None%
Sector positioning
Debt ratio
18.82024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMACIE DU CHENE VERT (18.80) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
73.48%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent
In 2024, the financial autonomy of PHARMACIE DU CHENE VERT (73.5%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.09 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE DU CHENE VERT (0.09) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 301.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
301.955
Liquidity indicators evolution PHARMACIE DU CHENE VERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
355.281
385.208
382.157
371.367
366.182
305.207
352.138
301.955
Interest coverage
0.24
0.065
None
None
None
0.0
None
None
Sector positioning
Liquidity ratio
301.952024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE DU CHENE VERT (301.95) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
0.0x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE DU CHENE VERT (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CHENE VERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
251 053 €
310 934 €
0 €
0 €
0 €
275 484 €
0 €
0 €
Inventory turnover (days)
35
38
0
0
0
36
0
0
Customer payment term (days)
4
5
0
0
0
2
0
0
Supplier payment term (days)
27
30
0
0
0
27
0
0
Positioning of PHARMACIE DU CHENE VERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU CHENE VERT is estimated at
927 607 €
(range 645 971€ - 1 387 753€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
645k€927k€1387k€
927 607 €Range: 645 971€ - 1 387 753€
NAF 5 année 2024
Valuation method used
Net Income Multiple
66 444 €
×
14.0x
=927 607 €
Range: 645 971€ - 1 387 754€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CHENE VERT with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CHENE VERT
What is the revenue of PHARMACIE DU CHENE VERT ?
The revenue of PHARMACIE DU CHENE VERT in 2022 is 2.0 M€.
Is PHARMACIE DU CHENE VERT profitable?
Yes, PHARMACIE DU CHENE VERT generated a net profit of 66 k€ in 2024.
Where is the headquarters of PHARMACIE DU CHENE VERT ?
The headquarters of PHARMACIE DU CHENE VERT is located in VALBONNE (06560), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE DU CHENE VERT ?
The tax return of PHARMACIE DU CHENE VERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CHENE VERT operate?
PHARMACIE DU CHENE VERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart